Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer



Status:Terminated
Conditions:Breast Cancer, Colorectal Cancer, Cancer, Cognitive Studies, Psychiatric
Therapuetic Areas:Oncology, Psychiatry / Psychology
Healthy:No
Age Range:65 - Any
Updated:4/21/2016
Start Date:March 2008
End Date:September 2011

Use our guide to learn which trials are right for you!

The Vulnerable Elders Survey Study of Older Cancer Patients

RATIONALE: Learning about changes over time in older patients' ability to function after
receiving chemotherapy for breast or colon cancer may help doctors learn about the long-term
effects of treatment and plan the best treatment.

PURPOSE: This clinical trial is studying older patients with newly diagnosed breast cancer
or colon cancer.

OBJECTIVES:

- Determine the correlation between the Vulnerable Elders Survey (VES-13) and the battery
of Comprehensive Geriatric Assessment tools among breast and colon cancer patients, 65
years and older, in an outpatient setting.

- Assess and compare the abilities of the VES-13 and the battery of Comprehensive
Geriatric Assessment tools to predict chemotherapy adherence among these patients.

- Examine the validity of the VES-13 screening tool to identify increased risk of death
from all causes at one year after initial VES-13 screening in these patients.

- Examine the validity of the VES-13 screening tool to identify increased risk of
functional decline at one year after initial VES-13 screening in these patients.

OUTLINE: Patients complete the Vulnerable Elders Survey (VES-13) and a Comprehensive
Geriatric Assessment at baseline and 12 months later. Variables collected include
sociodemographics; cognitive, nutritional, psychosocial, and emotional status; tumor
characteristics; therapy; and mortality.

Patients are followed for 1 year for chemotherapy adherence and survival.

DISEASE CHARACTERISTICS:

- Histologically confirmed breast or colon cancer

- Newly diagnosed disease

- Any stage disease

- Undergoing treatment at the Ireland Cancer Center, University Hospitals Case Medical
Center Site

- Scheduled to start a new chemotherapy regimen (objective II only)

- Not concurrently enrolled in a GEM trial (objectives II, III, and IV)

- Hormone receptor status not specified

PATIENT CHARACTERISTICS:

- Understands English

- Menopausal status not specified

PRIOR CONCURRENT THERAPY:

- See Diseases Characteristics
We found this trial at
5
sites
Mentor, Ohio 44060
?
mi
from
Mentor, OH
Click here to add this to my saved trials
11100 Euclid Ave
Cleveland, Ohio 44106
(216) 844-2273
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center We all know...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Orange Village, Ohio 44122
?
mi
from
Orange Village, OH
Click here to add this to my saved trials
South Euclid, Ohio 44121
?
mi
from
South Euclid, OH
Click here to add this to my saved trials
Westlake, Ohio 44145
?
mi
from
Westlake, OH
Click here to add this to my saved trials